COO
Cooper Companies, Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| free cash flow non-GAAP | $158.7M | first quarter | — |
| Non-GAAP operating margin non-GAAP | 27% | first quarter | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
COO
this stock
Cooper Companies, Inc.
|
$14.47B | -9.5% | +18.4% | 63.4 | 3.7% |
|
ISRG
Intuitive Surgical Inc
|
$150.88B | -24.8% | +20.5% | 51.8 | 2.2% |
|
MDLN
Medline Inc.
|
$119.55B | +2.8% | +11.5% | — | 2.1% |
|
BDX
Becton Dickinson & Co
|
$43.56B | +4.3% | +8.2% | — | 2.6% |
|
ALC
Alcon Inc
|
$33.97B | -11.6% | — | — | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| COO | +5.0% | +23.0% | -10.7% | +3.5% | -9.5% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +3.6% | +24.2% | -18.8% | +3.7% | -18.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.